Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Morgan Stanley analyst Vikram Purohit upgraded the rating for Ascendis Pharma A/S (NASDAQ:ASND) from Equal-Weight to Overweight and raised the price target from $180 to $250. Ascendis Pharma shares closed at $172.06 on Friday. See how other analysts view this stock.
  • Canaccord Genuity analyst Brian McNamara upgraded Worthington Enterprises, Inc. (NYSE:WOR) …

Full story available on Benzinga.com

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Morgan Stanley analyst Vikram Purohit upgraded the rating for Ascendis Pharma A/S (NASDAQ:ASND) from Equal-Weight to Overweight and raised the price target from $180 to $250. Ascendis Pharma shares closed at $172.06 on Friday. See how other analysts view this stock.
  • Canaccord Genuity analyst Brian McNamara upgraded Worthington Enterprises, Inc. (NYSE:WOR) …

Full story available on Benzinga.com

 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Morgan Stanley analyst Vikram Purohit upgraded the rating for Ascendis Pharma A/S (NASDAQ:ASND) from Equal-Weight to Overweight and raised the price target from $180 to $250. Ascendis Pharma shares closed at $172.06 on Friday. See how other analysts view this stock.
Canaccord Genuity analyst Brian McNamara upgraded Worthington Enterprises, Inc. (NYSE:WOR) …Full story available on Benzinga.com   Read MoreASND, News, RDDT, top upgrades, TWLO, WEN, WOR, Upgrades, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, WEN, US95058W1009, WOR, US9818111026, ASND, TWLO, RDDT, News, Upgrades, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets